Sonja Zweegman Selected Research

Sonja Zweegman Research Topics

Disease

91	Multiple Myeloma 02/2022 - 07/2005
28	Neoplasms (Cancer) 08/2022 - 11/2012
12	Leukemia 01/2021 - 10/2007
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2010
7	Hematologic Neoplasms (Hematological Malignancy) 06/2022 - 10/2010
7	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 11/2012
6	Infections 08/2022 - 05/2013
6	Disease Progression 12/2021 - 01/2014
5	Residual Neoplasm 11/2021 - 09/2005
5	Thrombocytopenia (Thrombopenia) 10/2019 - 10/2010
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 12/2013
4	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2016
3	Lymphoma (Lymphomas) 01/2022 - 04/2016
3	Frailty 01/2022 - 09/2017
3	Bone Diseases (Bone Disease) 01/2021 - 04/2012
3	Plasmacytoma 06/2020 - 01/2011
3	Amyloidosis 11/2019 - 05/2013
3	Essential Thrombocythemia 01/2016 - 11/2012
3	Renal Insufficiency (Renal Failure) 11/2014 - 01/2005
2	Neutropenia 08/2022 - 10/2021
2	Septic Shock (Toxic Shock Syndrome) 08/2022 - 10/2021
2	Fever (Fevers) 08/2022 - 01/2011
2	COVID-19 01/2022 - 01/2020
2	Testicular Neoplasms (Testicular Cancer) 01/2022 - 10/2010
2	Pain (Aches) 01/2021 - 12/2020
2	Inflammation (Inflammations) 12/2019 - 07/2005
2	Anemia 12/2017 - 10/2015
2	Hemorrhage 01/2017 - 01/2016
2	Thrombosis (Thrombus) 01/2017 - 01/2016
2	Splenomegaly 01/2016 - 08/2013
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 12/2002
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2015 - 01/2014
2	Polycythemia Vera 07/2014 - 11/2012
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2014 - 01/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2012 - 07/2002
2	alpha-Thalassemia 01/2007 - 01/2005
1	Febrile Neutropenia 08/2022
1	Pneumonia (Pneumonitis) 08/2022
1	Fever of Unknown Origin 08/2022
1	Respiratory Insufficiency (Respiratory Failure) 08/2022
1	Bronchiolitis Obliterans Syndrome 01/2022

Drug/Important Bio-Agent (IBA)

27	Bortezomib (Velcade)FDA Link 10/2021 - 07/2005
21	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2006
19	Thalidomide (Thalomid)FDA Link 10/2021 - 01/2008
18	daratumumabIBA 01/2022 - 01/2016
17	Proteasome InhibitorsIBA 01/2021 - 01/2013
16	Lenalidomide (CC 5013)FDA Link 01/2022 - 04/2010
13	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 02/2010
12	Monoclonal AntibodiesIBA 11/2021 - 05/2013
10	AntigensIBA 01/2022 - 12/2002
8	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2007
8	ixazomibIBA 01/2021 - 09/2017
7	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2017
7	carfilzomibIBA 08/2020 - 12/2013
7	Prednisone (Sone)FDA LinkGeneric 06/2020 - 07/2010
6	ruxolitinibIBA 01/2022 - 07/2017
6	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 12/2013
5	Pharmaceutical PreparationsIBA 08/2022 - 06/2013
5	fedratinibIBA 01/2022 - 07/2017
4	Immunoglobulin G (IgG)IBA 01/2022 - 06/2014
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2014
4	Rituximab (Mabthera)FDA Link 01/2017 - 01/2013
3	pomalidomideIBA 02/2022 - 09/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 02/2010
3	Immunomodulating AgentsIBA 01/2020 - 09/2017
3	Histone Deacetylase InhibitorsIBA 01/2018 - 07/2014
3	Syntex adjuvant formulationIBA 12/2017 - 11/2012
2	Biological ProductsIBA 01/2022 - 06/2014
2	Janus Kinase InhibitorsIBA 01/2022 - 01/2016
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021 - 01/2014
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2021 - 11/2020
2	Bispecific AntibodiesIBA 10/2021 - 11/2020
2	Zoledronic Acid (Zometa)FDA Link 01/2021 - 10/2015
2	CytokinesIBA 01/2021 - 01/2017
2	EpitopesIBA 01/2021 - 01/2019
2	Complement System Proteins (Complement)IBA 12/2020 - 12/2017
2	Immunoglobulin A (IgA)IBA 11/2020 - 06/2014
2	AntibodiesIBA 04/2020 - 01/2018
2	ADP-ribosyl Cyclase 1IBA 01/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2016
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 02/2015
2	Hemoglobins (Hemoglobin)IBA 10/2015 - 01/2007
2	Vorinostat FDA Link 07/2014 - 08/2013
2	PR-957IBA 01/2014 - 12/2013
2	L-SelectinIBA 06/2007 - 07/2005
1	Meropenem (Merrem)FDA LinkGeneric 08/2022
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 08/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 08/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022

Therapy/Procedure

46	Therapeutics 06/2022 - 01/2008
20	Stem Cell Transplantation 08/2022 - 12/2010
11	Drug Therapy (Chemotherapy) 08/2022 - 09/2005
3	Aftercare (After-Treatment) 01/2022 - 03/2011
3	Radiotherapy 01/2021 - 01/2016
3	Duration of Therapy 12/2020 - 03/2014
2	Precision Medicine 01/2021 - 01/2020
2	Transplantation 12/2020 - 01/2013
2	Erythrocyte Transfusion 12/2017 - 01/2017